Hostname: page-component-78c5997874-xbtfd Total loading time: 0 Render date: 2024-11-17T15:46:50.816Z Has data issue: false hasContentIssue false
  • English
  • Français

Diagnosis and Epidemiology of Parkinson's Disease

Published online by Cambridge University Press:  07 November 2014

Tanya Simuni  and
Matthew B. Stern
Get access Rights & Permissions [Opens in a new window]

Abstract

Parkinson's disease (PD) is one of the most common neurodegenerative diseases. The last 5 years have been marked by rapid developments in understanding the pathophysiology of PD as well as by the introduction of a number of new drugs for symptomatic treatment of the disease. On the other hand, the diagnosis of PD is still made purely on clinical grounds. Due to continuing advances in therapy, it is increasingly important to recognize PD in its earliest stages and to distinguish it from other causes of parkinsonism, for which prognosis and response to treatment differ. This article reviews the epidemiology of PD and then elaborates on the diagnosis and differential diagnosis.

Type
Feature Articles
Information
CNS Spectrums , Volume 3 , Issue 2: Pathophysiologic and Clinical Progress in Parkinson's Disease , February 1998 , pp. 23 - 35
Copyright
Copyright © Cambridge University Press 1998

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Kessler, II. Epidemiologic studies of Parkinson's disease. III. A community-based survey. Am J Epidemiol. 1972;96:242–254.Google Scholar
2.Parkinson, J. An Essay on the Shaking Palsy. London, England: Sherwood, Neely and Jones; 1817.Google Scholar
3.Mayeux, R, Denaro, J, Hemenegildo, N, et al.A population based investigation of Parkinson's disease with and without dementia: relationships to age and gender. Arch Neurol. 1992;42:492–497.Google Scholar
4.Harada, H, Nishikawa, S, Takahashi, K. Epidemiology of Parkinson's disease in a Japanese city. Arch Neurol. 1983;40:151–154.Google Scholar
5.Rosati, G, Granieri, E, Pinna, L, et al.The risk of Parkinson's disease in Mediterranean people. Neurology. 1980;30:250–255.Google Scholar
6.Quinn, N, Critchley, P, Marsden, CD. Young-onset Parkinson's disease. Mov Disord. 1987;2:73–91.CrossRefGoogle ScholarPubMed
7.Schoenberg, BS, Anderson, DW, Haerer, AF. Comparison of the prevalence of Parkinson's disease in the biracial population of Copiah County, Mississippi. Neurology. 1985;35:841–845.Google Scholar
8.Li, SC, Schoenberg, BS, Wang, CC, et al.A prevalence survey of Parkinson's disease and other movement disorders in the People's Republic of China. Arch Neurol. 1985;42:655–657.CrossRefGoogle ScholarPubMed
9.Schoenberg, BS, Osuntokun, BO, Adeuja, AOG, et al.Comparison of the prevalence of Parkinson's disease in black populations in the rural US and rural Nigeria: door-to-door community studies. Neurology. 1988;38:645–646.Google Scholar
10.Bharucha, NE, Bharucha, EP, Bharucha, AE, et al.Prevalence of Parkinson's disease in the Parsi community of Bombay, India. Arch Neurol. 1988;45:1321–1323.Google Scholar
11.Ballard, PA, Tetrud, JW, Langston, JW. Permanent human Parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahy-dropyridine (MPTP): seven cases. Neurology. 1985;35:949–956.Google Scholar
12.Tanner, CM, Chen, B, Wang, W, et al.Environmental factors in the etiology of Parkinson's disease. Can J Neurol Sci. 1987;4:419–423.Google Scholar
13.Tanner, CM, Langston, JW. Do environmental toxins cause Parkinson's disease? A critical review. Neurology. 1990;40(suppl 3):17–30.Google ScholarPubMed
14.Poskanzer, DC, Schwab, RS, Frazer, DW. Further observations on the cohort phenomenon in Parkinson's syndrome. In: Barbeau, A, Brunette, JR, eds. Progress in Neurogenetics. Amsterdam, Netherlands: Excerpta Medica Foundation; 1969:497–505.Google Scholar
15.Polymeropoulos, MH, Higgins, JJ, Golbe, LI, et al.Mapping of a gene for Parkinson's disease to chromosome 4q21-q23. Science. 1996;274:1197–1198.Google Scholar
16.Scott, WK, Stajich, JM, Yamaoka, LH. Genetic complexity and Parkinson's disease. Science. 1997;277:388–389.Google Scholar
17.Gibb, WRG, Lees, AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry. 1988;51:745–752.CrossRefGoogle Scholar
18.Hoehn, MM, Yahr, MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17:427–442.Google Scholar
19.Finley, L, Gresty, M, Halmagyi, G. Tremor, the cogwheel phenomenon and clonus in Parkinson's Disease. J Neurol Neurosurg Psychiatry. 1981;44:534–546.CrossRefGoogle Scholar
20.Geraghty, JJ, Jankovic, J, Zetusky, WJ. Association between essential tremor and Parkinson's disease. Ann Neurol. 1985;17:329–333.Google Scholar
21.Cleeves, L, Findley, LJ, Koller, W. Lack of association between essential tremor and Parkinson's disease. Ann Neurol. 1988;24:23–26.CrossRefGoogle ScholarPubMed
22.Koller, WC, Busenbark, K, Miner, K and the Essential Tremor Study Group. The relationship of essential tremor to other movement disorders: report on 678 patients. Ann Neurol. 1994;35:717–723.Google Scholar
23.Delwaide, PJ, Gonce, M. Pathophysiology of Parkinson's signs. In: Jankovic, J, Tolosa, E, eds. Parkinson's Disease and Movement Disorders. Baltimore, Md: Williams & Wilkins; 1993:77–80.Google Scholar
24.Lance, JW, Schwab, RS, Peterson, EA. Action tremor and the cogwheel phenomenon in Parkinson's disease. Brain. 1963;86:95–110.Google Scholar
25.Foerster, O. Zur Analyse und Pathophysiologie der straiten Bewegungstorungen. Zeit Neurol Psychiat. 1921;3:1–169.Google Scholar
26.Marsden, CD. Neurophysiology. In: Stern, G, ed. Parkinson's Disease. Baltimore, MD: the Johns Hopkins University Press; 1990:65–71.Google Scholar
27.Day, B, Dick, J, Marsden, CD. Patients with Parkinson's disease can employ a predictive motor strategy. J Neurol Neurosurg Psychiatry. 1984;47:1299–1306.Google Scholar
28.Jankovic, J, McDermott, M, Carter, J, et al.Variable expression of Parkinson's disease: a baseline analysis of the DATATOP cohort. Neurology. 1990;40:1529–1534.CrossRefGoogle ScholarPubMed
29.Hughes, AJ, Daniel, SE, Blankson, S, Lees, AJ. Accuracy of the clinical diagnosis of idiopathic Parkinson's disease: a clinicopathologic study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55:181–184.CrossRefGoogle ScholarPubMed
30.Hurtig, HI, Factor, SA, Hubble, JP, et al.Symptomatic parkinsonism. In: Stern, MB, Roller, WC, eds. Parkinsonian Syndromes. New York, NY: Marcel Dekker; 1993:81–203.Google Scholar
31.Steele, JC, Richardson, JC, Olszewski, J. Progressive supranuclear palsy: a heterogenous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia, and dementia. Arch Neurol. 1964;10:333–359.Google Scholar
32.Golbe, LI, David, PH, Schoenberg, BS, Duvoisin, RC. Prevalence and natural history of progressive supranuclear palsy. Neurology. 1988;38:1031–1034.Google Scholar
33.Litvan, I, Sasty, N, Sonies, BC. Characterizing swallowing abnormalities in progressive supranuclear palsy. Neurology. 1997;48:1654–1662.Google Scholar
34.Davis, PH, Bergeron, C, McLachlan, R. Atypical presentation of progressive supranuclear palsy. Ann Neurol. 1985;17:337–343.Google Scholar
35.Litvan, I, Agid, Y, eds. Progressive Supranuclear Palsy. Clinical and Research Approaches. New York, NY: Oxford University Press; 1992.Google Scholar
36.Colosimo, C, Albanese, A, Hughes, DJ, et al.Some specific clinical features differentiating multiple system atrophy (striatonigral variety) from Parkinson's disease. Arch Neurol. 1995;52:294–298.Google Scholar
37.Wenning, GK, Tison, F, Elliott, L, Quinn, NP, Daniel, SE. Olivopontocerebellar pathology in multiple system atrophy. Mov Dis. 1996;11:157–162.Google Scholar
38.Riley, DE, Lang, AE. Cortical basal ganglionic degeneration. In: Stern, MB, Koller, WC, eds. Parkinsonian, Syndromes. New York, NY: Marcel Dekker; 1993:379–392.Google Scholar
39.Pollock, M, Hornabrook, R. The prevalence, natural history and dementia of Parkinson's disease. Brain. 1966;89:429–448.Google Scholar
40.Mayeux, R, Denaro, J, Hemenegildo, N, et al.A population-based investigation of Parkinson's disease with and without dementia. Arch Neurol. 1992;49:492–497.Google Scholar
41.Rajput, A, Offord, K, Beard, CM. Epidemiological survey of dementia in Parkinsonism and control population. Ada Neurol. 1984;40:229–234.Google ScholarPubMed
42.Chui, HC, Teng, EL, Henderson, VW, Moy, AC. Clinical subtypes of dementia of the Alzheimer type. Neurology. 1985;35:1544–1550.Google Scholar
43.Mayeux, R, Stern, Y, Spanton, S. Heterogeneity in dementia of Alzheimer type: evidence of subgroups. Neurology. 1985;35:453–461.Google Scholar
44.Perry, RH, Irving, D, Blessed, G, et al.Senile dementia of Lewy body type: a clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci. 1990;95:119–139.CrossRefGoogle ScholarPubMed
45.Crystal, HA, Dickson, DW, Lizardi, JE, et al.Antemortem diagnosis of diffuse Lewy body disease. Neurology. 1990;40:1523–1528.Google Scholar
46.Filley, CM. Neuropsychiatric features of Lewy body disease. Brain Cogn. 1995;28:229–239.CrossRefGoogle ScholarPubMed
47.Kosaka, K, Yoshimura, M, Ikeda, K. Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree—new disease? Clin Neuropathol. 1984;3;185–192.Google Scholar
48.Stern, MB, Braffman, BH, Skolnick, BE, Hurtig, HI, Grossman, RI. Magnetic resonance imaging in Parkinson's disease and parkinsonian syndromes. Neurology. 1989;39:1524–1526.CrossRefGoogle ScholarPubMed
49.Rutledge, JN. Magnetic resonance of movement disorders. In: Jankovic, J, Tolosa, E, eds. Parkinson's Disease and Movement Disorders. Baltimore, Md: Williams & Wilkins; 1993:511–531.Google Scholar
50.Snow, BJ. Fluorodopa PET scanning in Parkinson's disease. In: Battistin, L, ed. Advances in Neurology. Vol. 69 (Parkinson's Disease). Philadelphia, Pa: Lippincott; 1996:449–457.Google Scholar
51.Federico, F, Simone, IL, Lucivero, V, et al.Proton magnetic resonance spectroscopy in Parkinson's disease and typical parkinsonian disorders. Mov Dis. 1997;12:903–909.Google Scholar
52.Marek, K, Parkinson Study Group. Dopascan and SPECT is a sensitive and specific tool for parkinsonism. PSG/MDS Eleventh Annual Symposium. Mov Dis. 1997;12:835. Abstract.Google Scholar
53.Riederer, P, Wuketich, S. Time course of nigrostriatal degeneration in Parkinson's disease: a detailed study of influential factors in human brain amine analogues. J Neural Trans Park Dis Dement Sect. 1976;38:277–301.Google Scholar
54.Brooks, DJ. Neuroimaging of movement disorders. In: Watts, RL, Koller, WC, eds. Movement Disorders. Neurologic Principles and Practice. New York: McGraw-Hill; 1996:34–36.Google Scholar
55.Burn, DJ, Mark, MH, Playford, ED, et al.Parkinson's disease in twins studied with 8F-dopa and positron emission tomography. Neurology. 1992;42:1894–1900.Google Scholar
56.Koller, WC, Montgomery, EB. Issues in the early diagnosis of Parkinson's disease. Neurology. 1997;49(suppl 1):S10–S25.Google Scholar